119 related articles for article (PubMed ID: 38704319)
1. Development and validation of a multicenter Cox regression model to predict all-cause mortality in patients with renal masses suspicious for renal cancer.
Lane BR; Cheaib JG; Boynton D; Pierorazio P; Noyes SL; Peabody H; Singla N; Johnson A; Ghani KR; Krumm A; Singh K
Urol Oncol; 2024 May; ():. PubMed ID: 38704319
[TBL] [Abstract][Full Text] [Related]
2. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a scoring system to predict mortality in patients hospitalized with COVID-19: A retrospective cohort study in two large hospitals in Ecuador.
Dueñas-Espín I; Echeverría-Mora M; Montenegro-Fárez C; Baldeón M; Chantong Villacres L; Espejo Cárdenas H; Fornasini M; Ochoa Andrade M; Solís C
PLoS One; 2023; 18(7):e0288106. PubMed ID: 37459312
[TBL] [Abstract][Full Text] [Related]
4. Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical Outcomes.
McIntosh AG; Ristau BT; Ruth K; Jennings R; Ross E; Smaldone MC; Chen DYT; Viterbo R; Greenberg RE; Kutikov A; Uzzo RG
Eur Urol; 2018 Aug; 74(2):157-164. PubMed ID: 29625756
[TBL] [Abstract][Full Text] [Related]
5. External Validation of the Prostate Cancer Specific Comorbidity Index: A Claims Based Tool for the Prediction of Life Expectancy in Men with Prostate Cancer.
Daskivich TJ; Thomas IC; Luu M; Shelton JB; Makarov DV; Skolarus TA; Leppert JT
J Urol; 2019 Sep; 202(3):518-524. PubMed ID: 31009286
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Delayed Intervention for Patients on Active Surveillance for Small Renal Masses: Does Renal Mass Biopsy Influence Our Decision?
Ambani SN; Morgan TM; Montgomery JS; Gadzinski AJ; Jacobs BL; Hawken S; Krishnan N; Caoili EM; Ellis JH; Kunju LP; Hafez KS; Miller DC; Palapattu GS; Weizer AZ; Wolf JS
Urology; 2016 Dec; 98():88-96. PubMed ID: 27450936
[TBL] [Abstract][Full Text] [Related]
7. A Nomogram to Predict Significant Estimated Glomerular Filtration Rate Reduction After Robotic Partial Nephrectomy.
Martini A; Cumarasamy S; Beksac AT; Abaza R; Eun DD; Bhandari A; Hemal AK; Porter JR; Badani KK
Eur Urol; 2018 Dec; 74(6):833-839. PubMed ID: 30224195
[TBL] [Abstract][Full Text] [Related]
8. Simplified cardiovascular index may be the best comorbidity index for clinical use in prediction of mortality for renal cancer patients.
Boynton D; Noyes SL; Murali A; Peabody H; Krumm A; Singh K; Lane BR
Urol Oncol; 2024 Mar; 42(3):72.e1-72.e8. PubMed ID: 38242826
[TBL] [Abstract][Full Text] [Related]
9. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
10. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
[No Abstract] [Full Text] [Related]
11. Predicting recurrence and survival in patients with non-metastatic renal-cell carcinoma after nephrectomy: a prospective population-based study with multicenter validation.
Wang Y; Xuan Y; Su B; Gao Y; Fan Y; Huang Q; Zhang P; Gu L; Niu S; Shen D; Li X; Wang B; Zhu Q; Ouyang Z; Xie J; Ma X
Int J Surg; 2024 Feb; 110(2):820-831. PubMed ID: 38016139
[TBL] [Abstract][Full Text] [Related]
12. A Predictive Model for Kidney Failure After Nephrectomy for Localized Kidney Cancer: The Kidney Cancer Risk Equation.
Harasemiw O; Nayak JG; Grubic N; Ferguson TW; Sood MM; Tangri N
Am J Kidney Dis; 2023 Dec; 82(6):656-665. PubMed ID: 37394174
[TBL] [Abstract][Full Text] [Related]
13. Balancing cardiovascular (CV) and cancer death among patients with small renal masses: modification by CV risk.
Patel HD; Kates M; Pierorazio PM; Allaf ME
BJU Int; 2015 Jan; 115(1):58-64. PubMed ID: 24589376
[TBL] [Abstract][Full Text] [Related]
14. Exploratory Subgroup Analyses of Renal Function and Overall Survival in European Organization for Research and Treatment of Cancer randomized trial of Nephron-sparing Surgery Versus Radical Nephrectomy.
Scosyrev E; Messing EM; Sylvester R; Van Poppel H
Eur Urol Focus; 2017 Dec; 3(6):599-605. PubMed ID: 28753863
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a predictive model for end-stage renal disease risk in patients with diabetic nephropathy confirmed by renal biopsy.
Sun L; Shang J; Xiao J; Zhao Z
PeerJ; 2020; 8():e8499. PubMed ID: 32095345
[TBL] [Abstract][Full Text] [Related]
16. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis.
Psutka SP; Gulati R; Jewett MAS; Fadaak K; Finelli A; Legere L; Morgan TM; Pierorazio PM; Allaf ME; Herrin J; Lohse CM; Houston Thompson R; Boorjian SA; Atwell TD; Schmit GD; Costello BA; Shah ND; Leibovich BC
Eur Urol; 2022 Jun; 81(6):576-585. PubMed ID: 34862099
[TBL] [Abstract][Full Text] [Related]
17. The type of nephrectomy has little effect on overall survival or cardiac events in patients of 70 years and older with localized clinical t1 stage renal masses.
Kyung YS; You D; Kwon T; Song SH; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
Korean J Urol; 2014 Jul; 55(7):446-52. PubMed ID: 25045442
[TBL] [Abstract][Full Text] [Related]
18. Selecting Patients with Small Renal Masses for Active Surveillance: A Domain Based Score from a Prospective Cohort Study.
Sotimehin AE; Patel HD; Alam R; Gorin MA; Johnson MH; Chang P; Wagner AA; McKiernan JM; Allaf ME; Pierorazio PM
J Urol; 2019 May; 201(5):886-892. PubMed ID: 30694934
[TBL] [Abstract][Full Text] [Related]
19. Active treatment of localized renal tumors may not impact overall survival in patients aged 75 years or older.
Lane BR; Abouassaly R; Gao T; Weight CJ; Hernandez AV; Larson BT; Kaouk JH; Gill IS; Campbell SC
Cancer; 2010 Jul; 116(13):3119-26. PubMed ID: 20564627
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
